This program will address current trends in cannabis securities litigation. Participants can expect to receive information on a variety of cannabis-related securities cases, including the most recent of such cases, which was filed in April 2022. Participants will learn about the current strategies taken in securities actions through cases at varying stages of litigation.
Upon completion of this program, participants should expect to be able to identify common causes of action levied against cannabis-related entities and strategies those entities can implement to mitigate risk.
From patents and plant breeder’s rights, to trademarks and trade secrets, participants will learn how to approach the evolving practice of cannabis IP across several illustrative jurisdictions including Germany, Canada and the United States.
A practical guide on pointers and pitfalls in crafting ADR clauses in contracts to save your clients time and money. The panel will discuss everything from choice of law, venue selection, arbitrator qualifications, "cooling off" and mediation requirements, discovery provisions and appellate options.
Learn about the licensing considerations, continuing obligations, and risk related to physical security in the cannabis industry, from mapping your business to liaising with law enforcement, and from environmental and procedural security to best practices in security employee training, join us to go through the intricacies of security in the cannabis industry.
Participants will learn about the basic limitations and barriers of the cannabis market in Poland from the perspective of cultivators, manufacturers, sellers and patients.
In this session, hear from attorneys who are actively working on applications in the Garden State and with clients who are investing in New Jersey or otherwise gearing up for future submissions. Learn about unique-to-New Jersey license types, such as the “Conditional License,” enabling prospective operators to apply for a license without site control (subject to income restrictions), the “Micro-license,” a 2500 square foot facility for which there are no caps (subject to residency requirements), priorities in licensing, and creative opportunities to participate in the market distinct from ownership (via “Financial Source Agreement” or “Management Services Agreement”). Also learn about how the regulatory process is unfolding and how administrative delays are impacting the licensing process and accompanying operational timelines and legal transactions.
Attendees will gain an overview of the UK Cannabis markets, including an overview of the small but growing medical segment, as well as the booming CBD and wellness industries.